Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
Dow
Argus Health
Cantor Fitzgerald
Daiichi Sankyo
Farmers Insurance
Federal Trade Commission
Express Scripts

Generated: September 20, 2018

DrugPatentWatch Database Preview

Lundbeck Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for LUNDBECK PHARMS LLC, and what generic alternatives to LUNDBECK PHARMS LLC drugs are available?

LUNDBECK PHARMS LLC has five approved drugs.

There are six US patents protecting LUNDBECK PHARMS LLC drugs.

Summary for Lundbeck Pharms Llc
US Patents:6
Tradenames:3
Ingredients:3
NDAs:5

Drugs and US Patents for Lundbeck Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-001 Oct 21, 2011 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;INTRAVENOUS 206030-001 Oct 7, 2016 DISCN Yes No 9,750,822 ➤ Try a Free Trial Y ➤ Try a Free Trial
Lundbeck Pharms Llc ONFI clobazam SUSPENSION;ORAL 203993-001 Dec 14, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-003 Oct 21, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;INTRAVENOUS 206030-001 Oct 7, 2016 DISCN Yes No 9,770,407 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents for Lundbeck Pharms Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,200,088 Sulfoalkyl ether cyclodextrin compositions ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Dow
Merck
Chubb
McKesson
Accenture
Deloitte
Cerilliant
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.